(E/Z)-3-((6-Methyl-[5,6'-biimidazo[2,1-b]thiazol]-5'-yl)methylene)-1,3-dihydro-2H-benzo[g]indol-2-one

ID: ALA4452311

Chembl Id: CHEMBL4452311

PubChem CID: 155523011

Max Phase: Preclinical

Molecular Formula: C25H17N5OS2

Molecular Weight: 467.58

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cn2c(C=C3C(=O)Nc4c3ccc3ccccc43)c(-c3c(C)nc4sccn34)nc2s1

Standard InChI:  InChI=1S/C25H17N5OS2/c1-13-12-30-19(21(28-25(30)33-13)22-14(2)26-24-29(22)9-10-32-24)11-18-17-8-7-15-5-3-4-6-16(15)20(17)27-23(18)31/h3-12H,1-2H3,(H,27,31)

Standard InChI Key:  UUWASUXDJXZOLW-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4452311

    ---

Associated Targets(Human)

Leukemia cell (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NSCLC (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNS carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell line (83 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovarian carcinoma cell (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Renal cancer cell line (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prostatic carcinoma cell (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Breast carcinoma cell (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

TUBB2B Tubulin (2175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.58Molecular Weight (Monoisotopic): 467.0875AlogP: 6.03#Rotatable Bonds: 2
Polar Surface Area: 63.70Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.79CX Basic pKa: 3.60CX LogP: 4.55CX LogD: 4.54
Aromatic Rings: 6Heavy Atoms: 33QED Weighted: 0.32Np Likeness Score: -1.28

References

1. Morigi R, Locatelli A, Leoni A, Rambaldi M, Bortolozzi R, Mattiuzzo E, Ronca R, Maccarinelli F, Hamel E, Bai R, Brancale A, Viola G..  (2019)  Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents.,  166  [PMID:30784885] [10.1016/j.ejmech.2019.01.049]

Source